Correlation Between Motus GI and Heart Test
Can any of the company-specific risk be diversified away by investing in both Motus GI and Heart Test at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Motus GI and Heart Test into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Motus GI Holdings and Heart Test Laboratories, you can compare the effects of market volatilities on Motus GI and Heart Test and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Motus GI with a short position of Heart Test. Check out your portfolio center. Please also check ongoing floating volatility patterns of Motus GI and Heart Test.
Diversification Opportunities for Motus GI and Heart Test
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Motus and Heart is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Motus GI Holdings and Heart Test Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heart Test Laboratories and Motus GI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Motus GI Holdings are associated (or correlated) with Heart Test. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heart Test Laboratories has no effect on the direction of Motus GI i.e., Motus GI and Heart Test go up and down completely randomly.
Pair Corralation between Motus GI and Heart Test
If you would invest (100.00) in Motus GI Holdings on December 28, 2024 and sell it today you would earn a total of 100.00 from holding Motus GI Holdings or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Motus GI Holdings vs. Heart Test Laboratories
Performance |
Timeline |
Motus GI Holdings |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Heart Test Laboratories |
Motus GI and Heart Test Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Motus GI and Heart Test
The main advantage of trading using opposite Motus GI and Heart Test positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Motus GI position performs unexpectedly, Heart Test can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will offset losses from the drop in Heart Test's long position.Motus GI vs. ENDRA Life Sciences | Motus GI vs. Electrocore LLC | Motus GI vs. Check Cap | Motus GI vs. Vyne Therapeutics |
Heart Test vs. Tivic Health Systems | Heart Test vs. Bluejay Diagnostics | Heart Test vs. Nuwellis | Heart Test vs. NeuroMetrix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |